Outlook therapeutics, inc. (OTLK)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Jun'15Mar'15
Collaboration revenues

-

-

8,146

3,064

3,252

3,383

3,087

5,217

4,749

4,280

3,811

1,404

1,596

2,287

2,979

0

3,779

0

0

0

Operating expenses:
Research and development

22,028

23,581

23,805

23,550

24,952

24,173

18,504

13,662

12,023

10,984

23,809

25,375

33,235

33,256

32,763

0

36,707

0

0

0

General and administrative

8,910

8,802

9,369

12,623

12,985

13,582

14,227

11,696

12,982

14,560

15,882

18,950

25,973

21,760

21,563

0

11,486

0

0

0

Impairment of property and equipment

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

39,721

41,304

44,445

39,085

40,849

40,105

32,731

25,359

25,006

25,545

39,691

44,326

59,209

55,017

54,326

0

48,194

0

0

0

Loss from operations

-33,283

-34,225

-36,299

-36,020

-37,596

-36,721

-29,644

-20,141

-20,257

-21,264

-35,880

-42,922

-57,613

-52,729

-51,347

0

-44,414

0

0

0

Interest expense, net

2,585

2,943

3,466

4,361

4,427

4,294

3,891

4,933

5,531

5,854

5,625

4,094

2,647

1,941

1,851

0

2,197

0

0

0

Loss on extinguishment of debt

-8,667

0

-

0

0

-

-1,252

0

0

0

-

-

-

-

-

-

-

-

-

-

Change in fair value of redemption feature

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-2,305

-1,003

-2,438

-3,087

-1,091

-2,605

-1,047

591

-3,223

-4,047

-3,158

0

0

0

-

0

-

-

-

-

Loss before income taxes

-

-

-

-37,902

-

-

-33,740

-26,918

-23,818

-24,324

-38,347

-43,039

-60,035

-55,481

-53,198

0

-46,612

0

0

0

Income tax benefit

-

-

-

0

-

-

-3,648

-2,653

-2,653

-2,653

501

4

4

55

103

0

-503

0

0

0

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Less: Net loss attributable to noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net loss

-36,840

-41,384

-34,523

-36,627

-40,618

-37,913

-30,091

-24,265

-21,165

-21,671

-38,849

-43,043

-60,039

-55,536

-53,301

0

-45,728

0

0

0

Beneficial conversion feature upon issuance of Series A-1 convertible preferred stock

-

-

-

-

0

-

16,022

0

0

0

-

-

-

-

-

-

-

-

-

-

Series A-1 convertible preferred stock dividends and related settlement

486

640

624

626

1,121

1,603

1,903

0

0

0

-

-

-

-

-

-

-

-

-

-

Deemed dividend upon modification of warrants

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend upon amendment of the terms of the Series A-1 convertible preferred stock

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable preferred stock and noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,463

0

4,096

0

0

0

Deemed dividends upon the repurchase of Series A redeemable preferred stock and redeemable noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Deemed dividend upon issuance of warrants to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Net loss attributable to common stockholders

-50,794

-44,625

-36,039

-38,431

-42,916

-40,184

-48,018

-42,919

-39,165

-38,653

-40,025

-43,043

-67,906

-64,433

-63,138

0

-49,891

0

0

0

Per share information:
Net loss per share of common stock, basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-0.22

-0.34

-

-

-1.60

-0.32

-

-

-

Net loss per share of common stock, diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-0.22

-0.38

-

-

-1.60

-0.32

-

-

-

Weighted average shares outstanding, basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

24,442

23,723

-

-

18,816

14,155

-

-

-

Weighted average shares outstanding, diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

24,442

23,801

-

-

18,816

14,155

-

-

-

Net loss per share of common stock, basic and diluted (in dollars per share)

-0.36

-0.62

0.20

-0.20

-0.98

-1.00

-4.27

-2.10

-2.66

-0.71

-

-

-

-0.82

-

-

-

-1.36

-1.30

-1.61

Weighted average shares outstanding, basic and diluted (in shares)

47,895

29,901

28,387

23,007

11,529

9,843

-12,808

4,317

3,216

25,003

-

-

-

23,196

-

-

-

13,061

9,588

9,377